Lisinopril and kidney function
Pro Research Analysisby 
Searched over 200M research papers
Lisinopril and Kidney Function in Diabetic Nephropathy
Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, has been studied extensively for its effects on kidney function, especially in patients with diabetic nephropathy. Research comparing lisinopril to atenolol, a beta-blocker, in hypertensive patients with non-insulin-dependent diabetes mellitus (NIDDM) and diabetic nephropathy found that both drugs slowed the progression of kidney function decline equally when blood pressure was controlled. However, lisinopril was significantly more effective at reducing albuminuria, a marker of kidney damage, than atenolol, suggesting a specific renoprotective effect beyond blood pressure control alone Nielsen1994Nielsen1997.
Lisinopril in Early Diabetic Kidney Disease
In normotensive patients with insulin-dependent diabetes and either normal or slightly elevated albuminuria, lisinopril slowed the progression of kidney disease, with the greatest benefit seen in those with microalbuminuria. Importantly, lisinopril did not increase the risk of hypoglycemic events, making it a safe option for early intervention in diabetic kidney disease .
Lisinopril and Non-Diabetic Chronic Kidney Disease
For patients with non-diabetic chronic kidney disease and mild proteinuria, lisinopril was more effective than other antihypertensive agents in slowing the decline of kidney function, even when blood pressure was similarly controlled in both groups. This supports the idea that ACE inhibitors like lisinopril have a specific protective effect on the kidneys, not just through lowering blood pressure but also by directly affecting kidney function .
Lisinopril in Renal Transplant Recipients
In hypertensive renal transplant recipients with proteinuria, lisinopril effectively lowered blood pressure and reduced proteinuria without causing significant changes in glomerular filtration rate (GFR) or serum creatinine. Renal plasma flow increased and renal vascular resistance decreased, indicating improved kidney blood flow. However, when compared to nifedipine, another antihypertensive, nifedipine was associated with a greater improvement in kidney transplant function over two years, though both drugs were safe and effective for blood pressure control Traindl1993Midtvedt2001.
Lisinopril Pharmacokinetics in Chronic Renal Failure
In patients with stable chronic renal failure, lisinopril did not alter creatinine clearance, indicating that it does not worsen kidney function in this population. However, serum potassium levels may rise, so monitoring is recommended .
Lisinopril in Animal Models and Genetic Kidney Disease
Animal studies have shown that lisinopril, especially when combined with other agents like dapagliflozin, can rescue GFR decline and reduce kidney damage in models of diabetic kidney disease. In mouse models with APOL1 high-risk genetic variants, lisinopril significantly reduced proteinuria and glomerulosclerosis, particularly in certain genetic backgrounds, suggesting that its effectiveness may vary depending on genetic factors Van Koppen2024Karreci2024.
Lisinopril and Renal Dysfunction in Other Conditions
In patients with chronic toxic hepatitis and associated renal dysfunction, lisinopril improved both liver and kidney function, particularly by enhancing filtration processes and increasing diuresis, sodium, and potassium excretion. This suggests a broader role for lisinopril in improving kidney adaptive function in various disease states .
Conclusion
Lisinopril is effective in slowing the progression of kidney disease in both diabetic and non-diabetic patients, with particular benefits in reducing proteinuria and protecting kidney function beyond blood pressure control. Its safety profile is generally favorable, though monitoring for increased potassium is advised. The renoprotective effects of lisinopril are evident across a range of kidney diseases and patient populations, making it a valuable option in the management of chronic kidney disease.
Sources and full results
Most relevant research papers on this topic
Impact of Lisinopril and Atenolol on Kidney Function in Hypertensive NIDDM Subjects With Diabetic Nephropathy
Lisinopril effectively reduces albuminuria more than atenolol in hypertensive NIDDM patients with diabetic nephropathy, potentially improving kidney function.
Effect of Lisinopril on the progression of renal insufficiency in mild proteinuric non-diabetic nephropathies.
Lisinopril has a specific renoprotective effect in addition to blood pressure control in patients with mild proteinuria, slowing the progression of non-diabetic chronic renal diseases.
DOI